Cargando…
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease
Background: Stargardt Disease is the most common inherited macular degeneration, typically resulting in progressive central vision loss and legal blindness at an early age. We report regarding 34 eyes with Stargardt Disease treated in the Stem Cell Ophthalmology Treatment Study (SCOTS and SCOTS2). M...
Autores principales: | Weiss, Jeffrey N., Levy, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913552/ https://www.ncbi.nlm.nih.gov/pubmed/33546345 http://dx.doi.org/10.3390/medicines8020010 |
Ejemplares similares
-
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration
por: Weiss, Jeffrey N., et al.
Publicado: (2020) -
Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy
por: Weiss, Jeffrey N., et al.
Publicado: (2016) -
Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment
por: Weiss, Jeffrey N., et al.
Publicado: (2016) -
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report
por: Weiss, Jeffrey N., et al.
Publicado: (2015) -
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy
por: Weiss, Jeffrey N., et al.
Publicado: (2015)